DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 073025
, which is a drug marketed by Zydus Pharms Usa, Pliva, Alvogen Malta, Able, Sun Pharm Inds Inc, Aurobindo Pharma, Teva, Apothecon, Teva Pharms, Sandoz, Mylan, Nostrum Labs, Dava Pharms Inc, Unique Pharm Labs, Watson Labs, Watson Labs Teva, Northstar Hlthcare, Sun Pharm Inds, SCS, Ipca Labs Ltd, and Mutual Pharm, and is included in forty-one NDAs. It is available from fifty-six suppliers. Additional details are available on the ATENOLOL profile page.
The generic ingredient in ATENOLOL is atenolol; chlorthalidone. There are thirty-three drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the atenolol; chlorthalidone profile page.
Pharmacology for NDA: 073025
Suppliers and Packaging for NDA: 073025
||National Drug Code
||100 TABLET in 1 BOTTLE (0781-1506-01)
||500 TABLET in 1 BOTTLE (0781-1506-05)
|Complete Access Available with Subscription
Summary for product number 001
|Approval Date:||Sep 17, 1991||TE:||AB||RLD:||No|
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.